Advanced search
Publication Cover
ImmunoTargets and Therapy Volume 10, 2021 - Issue
Submit an article Journal homepage
339
Views
19
CrossRef citations to date
0
Altmetric
Review

VISTA: A Promising Target for Cancer Immunotherapy?

Marco Tagliamento1 Department of Medical Oncology, Medical Oncology 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy;2 Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genova, Genova, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7461-023XView further author information
ORCID Icon,
Elisa Agostinetto3 Institut Jules Bordet and Université Libre de Bruxelles (U.L.B), Brussels, Belgium;4 Medical Oncology and Hematology Unit, IRCCS Humanitas Clinical and Research Center and Humanitas University, Milan, ItalyView further author information
,
Roberto Borea2 Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genova, Genova, Italy;5 Department of Medical Oncology, Medical Oncology 1, IRCCS Ospedale Policlinico San Martino, Genova, ItalyORCID Iconhttps://orcid.org/0000-0001-5403-0916View further author information
ORCID Icon,
Mariana Brandão3 Institut Jules Bordet and Université Libre de Bruxelles (U.L.B), Brussels, BelgiumView further author information
,
Francesca Poggio6 Breast Unit, IRCCS Ospedale Policlinico San Martino, Genova, ItalyView further author information
,
Alfredo Addeo7 Oncology Department, University Hospital of Geneva, Geneva, SwitzerlandORCID Iconhttps://orcid.org/0000-0003-0988-0828View further author information
ORCID Icon &
Matteo Lambertini2 Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genova, Genova, Italy;8 Department of Medical Oncology, UOC Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, ItalyORCID Iconhttps://orcid.org/0000-0003-1797-5296View further author information
ORCID Icon show all
Pages 185-200 | Published online: 22 Jun 2021

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Elisa Agostinetto, Agnese Losurdo, Guilherme Nader-Marta, Armando Santoro, Kevin Punie, Romualdo Barroso, Lazar Popovic, Cinzia Solinas, Marleen Kok, Evandro de Azambuja & Matteo Lambertini. (2022) Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer. Expert Opinion on Investigational Drugs 31:6, pages 567-591.
Read now

Articles from other publishers (18)

Ibtissam Rezouki, Basma Zohair, Saadia Ait Ssi, Mehdi Karkouri, Ibtissam Razzouki, Mohamed Elkarroumi & Abdallah Badou. (2023) High VISTA expression is linked to a potent epithelial-mesenchymal transition and is positively correlated with PD1 in breast cancer. Frontiers in Oncology 13.
Crossref
Francesco Lasorsa, Nicola Antonio di Meo, Monica Rutigliano, Martina Milella, Matteo Ferro, Savio Domenico Pandolfo, Felice Crocetto, Octavian Sabin Tataru, Riccardo Autorino, Michele Battaglia, Pasquale Ditonno & Giuseppe Lucarelli. (2023) Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice. Biomedicines 11:4, pages 1071.
Crossref
Kevin Yao, Emily Zhou, Evelien Schaafsma, Baoyi Zhang & Chao Cheng. (2022) Immune checkpoint gene VSIR predicts patient prognosis in acute myeloid leukemia and myelodysplastic syndromes . Cancer Medicine 12:5, pages 5590-5602.
Crossref
Shovan Dutta, Anirban Ganguly, Kaushiki Chatterjee, Sheila Spada & Sumit Mukherjee. (2023) Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors. Biology 12:2, pages 218.
Crossref
Shi-Yao Wei, Bei Feng, Min Bi, Hai-Ying Guo, Shang-Wei Ning & Rui Cui. (2022) Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma. BMC Medical Genomics 15:1.
Crossref
Joshua Tobias, Mirjana Drinić, Anna Schmid, Anastasiya Hladik, Martin L. Watzenböck, Claire Battin, Erika Garner-Spitzer, Peter Steinberger, Michael Kundi, Sylvia Knapp, Christoph C. Zielinski & Ursula Wiedermann. (2022) Combined Vaccination with B Cell Peptides Targeting Her-2/neu and Immune Checkpoints as Emerging Treatment Option in Cancer. Cancers 14:22, pages 5678.
Crossref
Shuxin Huang, Yujie Zhao, Pengjun Liao, Jinghua Wang, Zhiyan Li, Jiaxiong Tan, Xianfeng Zha, Shaohua Chen, Yangqiu Li & Liye Zhong. (2022) Different expression patterns of VISTA concurrent with PD-1, Tim-3, and TIGIT on T cell subsets in peripheral blood and bone marrow from patients with multiple myeloma. Frontiers in Oncology 12.
Crossref
Kyung-Soo Chun, Do-Hee Kim, Pawan Kumar Raut & Young-Joon Surh. (2022) Anticancer natural products targeting immune checkpoint protein network. Seminars in Cancer Biology 86, pages 1008-1032.
Crossref
Rong Fan, Nathan De Beule, Anke Maes, Elke De Bruyne, Eline Menu, Karin Vanderkerken, Ken Maes, Karine Breckpot & Kim De Veirman. (2022) The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers. Frontiers in Immunology 13.
Crossref
Mi Zhang, Juan Zhang, Na Liu, Biyuan Wang, Yan Zhou & Jin Yang. (2022) VISTA is associated with immune infiltration and predicts favorable prognosis in TNBC. Frontiers in Oncology 12.
Crossref
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, D. S. Prabakaran, Raja Ganesan, Kaviyarasi Renu, Abhijit Dey, Balachandar Vellingiri, Sabariswaran Kandasamy, Thiyagarajan Ramesh & Abilash Valsala Gopalakrishnan. (2022) The Cellular and Molecular Immunotherapy in Prostate Cancer. Vaccines 10:8, pages 1370.
Crossref
Tongguo Shi, Shuru Zhou, Ting Zhang, Shiyang Han, Li Zhang, Fengqing Fu, Ruhong Yan & Xueguang Zhang. (2022) Establishment of a Monoclonal Antibody-Based Enzyme-Linked Immunosorbent Assay to Measure Soluble B7-H5 in Patients with Cancer. Journal of Immunology Research 2022, pages 1-8.
Crossref
Markus Albertsmeier, Annelore Altendorf-Hofmann, Lars H. Lindner, Rolf D. Issels, Eric Kampmann, Hans-Roland Dürr, Martin K. Angele, Frederick Klauschen, Jens Werner, Achim A. Jungbluth & Thomas Knösel. (2022) VISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?. Cancers 14:4, pages 1006.
Crossref
Julio C. Osorio, Rancés Blanco, Alejandro H. Corvalán, Juan P. Muñoz, Gloria M. Calaf & Francisco Aguayo. (2022) Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives. Pathogens 11:2, pages 132.
Crossref
Andreea Cătălina Tinca, Iuliu Gabriel Cocuz, Mihaela Cornelia Șincu, Raluca Niculescu, Adrian Horațiu Sabău, Diana Maria Chiorean, Andreea Raluca Szőke & Ovidiu Simion Cotoi. (2022) VISTA, PDL-L1, and BRAF—A Review of New and Old Markers in the Prognosis of Melanoma. Medicina 58:1, pages 74.
Crossref
Katrin Pansy, Barbara Uhl, Jelena Krstic, Marta Szmyra, Karoline Fechter, Ana Santiso, Lea Thüminger, Hildegard Greinix, Julia Kargl, Katharina Prochazka, Julia Feichtinger & Alexander JA. Deutsch. (2021) Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions. International Journal of Molecular Sciences 22:24, pages 13311.
Crossref
Andreia Gameiro, Catarina Nascimento, Jorge Correia & Fernando Ferreira. (2021) VISTA Is a Diagnostic Biomarker and Immunotherapy Target of Aggressive Feline Mammary Carcinoma Subtypes. Cancers 13:21, pages 5559.
Crossref
Olga Rodak, Manuel David Peris-Díaz, Mateusz Olbromski, Marzenna Podhorska-Okołów & Piotr Dzięgiel. (2021) Current Landscape of Non-Small Cell Lung Cancer: Epidemiology, Histological Classification, Targeted Therapies, and Immunotherapy. Cancers 13:18, pages 4705.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.